Disseminated Fusarium infection in autologous stem cell transplant recipient

Vivian Iida Avelino-Silva1, Jessica Fernandes Ramos1, Fabio Eudes Leal2

  • 1Department of Infectious and Parasitic Diseases, University of Sao Paulo Medical School, São Paulo, SP, Brazil; Hospital Sirio-Libanês, Sao Paulo, SP, Brazil.

Insights

Disseminated Fusarium infection is a rare, lethal condition in immunocompromised patients. This case highlights a fatal Fusarium infection in an autologous bone marrow transplant recipient, challenging previous risk assumptions.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Hematology

Background:

  • Disseminated Fusarium infection is a severe, often fatal, opportunistic mycosis.
  • It primarily affects individuals with profound cellular immunodeficiency, such as recipients of allogeneic hematopoietic stem cell transplants.
  • Autologous bone marrow transplant recipients are generally considered at lower risk for invasive fungal infections like fusariosis.

Observation:

  • This report details an unusual case of disseminated Fusarium infection.
  • The patient was an autologous bone marrow transplant recipient.
  • The infection occurred during the pre-engraftment phase, a critical period of immunosuppression.

Findings:

  • The patient developed a lethal disseminated Fusarium infection.
  • This outcome is unexpected given the patient's autologous transplant status.
  • The findings suggest a potential underestimation of fusariosis risk in certain autologous transplant scenarios.

Implications:

  • This case underscores the need for heightened vigilance regarding Fusarium infections in allogeneic and potentially autologous bone marrow transplant recipients.
  • It may prompt a re-evaluation of risk stratification and prophylactic strategies for invasive fungal infections post-transplant.
  • Further research is warranted to understand the specific factors contributing to fusariosis development in autologous transplant settings.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.9K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.7K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K